Assurant 2014 Annual Report Download - page 112

Download and view the complete annual report

Please find page 112 of the 2014 Assurant annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 161

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161

ASSURANT, INC. – 2014 Form 10-KF-24
5 Investments
Loan-to-Value
December 31, 2013
Carrying Value % of Gross Mortgage Loans Debt-Service Coverage Ratio
70% and less $ 1,143,200 88.5% 1.97
71 – 80% 73,603 5.7% 1.44
81 – 95% 58,752 4.6% 1.19
Greater than 95% 15,959 1.2% 0.87
Gross commercial mortgage loans 1,291,514 100.0% 1.89
Less valuation allowance (4,482)
Net commercial mortgage loans $ 1,287,032
All commercial mortgage loans that are individually impaired
have an established mortgage loan valuation allowance for
losses. Changing economic conditions affect our valuation of
commercial mortgage loans. Changing vacancies and rents
are incorporated into the discounted cash ow analysis
that we perform for monitored loans and may contribute
to the establishment of (or an increase or decrease in) a
commercial mortgage loan valuation allowance for losses.
In addition, we continue to monitor the entire commercial
mortgage loan portfolio to identify risk. Areas of emphasis are
properties that have exposure to speci c geographic events,
have deteriorating credits or have experienced a reduction
in debt-service coverage ratio. Where warranted, we have
established or increased a valuation allowance based upon
this analysis.
The commercial mortgage loan valuation allowance for losses
was $3,399 and $4,482 at December 31, 2014 and 2013,
respectively. In 2014 and 2013, the loan valuation allowance
was decreased $1,083 and $2,515, respectively, due to
changing economic conditions and geographic concentrations.
At December 31, 2014, the Company had mortgage loan
commitments outstanding of approximately $26,959. The
Company is also committed to fund additional capital
contributions of $5,320 to partnerships.
The Company has short term investments and xed maturities
of $519,659 and $543,344 at December 31, 2014 and 2013,
respectively, on deposit with various governmental authorities
as required by law.
The Company utilizes derivative instruments in managing the
Assurant Solutions segment preneed life insurance business
exposure to in ation risk. The derivative instruments,
Consumer Price Index Caps (the “CPI CAPs”), limits the
in ation risk on certain policies. The CPI CAPs do not
qualify under GAAP as effective hedges; therefore, they
are marked-to-market on a quarterly basis and the gain or
loss is recognized in the statement of operations in fees and
other income. As of December 31, 2014 and 2013, the CPI
CAPs included in other assets on the consolidated balance
sheet amounted to $807 and $2,491, respectively. The loss
recorded in the results of operations totaled $1,684, $3,395,
and $2,635 for the years ended December 31, 2014, 2013
and 2012, respectively.
Collateralized Transactions
The Company engages in transactions in which xed maturity
securities, primarily bonds issued by the U.S. government and
government agencies and authorities, and U.S. corporations,
are loaned to selected broker/dealers. Collateral, greater
than or equal to 102% of the fair value of the securities lent,
plus accrued interest, is received in the form of cash and cash
equivalents held by a custodian bank for the bene t of the
Company. The use of cash collateral received is unrestricted.
The Company reinvests the cash collateral received, generally
in investments of high credit quality that are designated as
available-for-sale. The Company monitors the fair value of
securities loaned and the collateral received, with additional
collateral obtained, as necessary. The Company is subject
to the risk of loss to the extent there is a loss on the re-
investment of cash collateral.
As of December 31, 2014 and 2013, our collateral held
under securities lending, of which its use is unrestricted,
was $95,985 and $95,215, respectively, and is included in
the consolidated balance sheets under the collateral held/
pledged under securities agreements. Our liability to the
borrower for collateral received was $95,986 and $95,206,
respectively, and is included in the consolidated balance
sheets under the obligation under securities agreements.
The difference between the collateral held and obligations
under securities lending is recorded as an unrealized gain
(loss) and is included as part of AOCI. All securities with
unrealized losses have been in a continuous loss position for
less than 12 months as of December 31, 2014. All securities
were in an unrealized gain position as of December 31, 2013.
The Company includes the available-for-sale investments
purchased with the cash collateral in its evaluation of other-
than-temporary impairments.
Cash proceeds that the Company receives as collateral for
the securities it lends and subsequent repayment of the cash
are regarded by the Company as cash ows from nancing
activities, since the cash received is considered a borrowing.
Since the Company reinvests the cash collateral generally
in investments that are designated as available-for-sale,
the reinvestment is presented as cash ows from investing
activities.